AR087081A1 - (1r,4r)-6-fluoro-n,n-dimetil-4-fenil-4,9-dihidro-3h-espiro[ciclohexano-1,1-pirano[3,4-b]indol]-4-amina cristalina - Google Patents

(1r,4r)-6-fluoro-n,n-dimetil-4-fenil-4,9-dihidro-3h-espiro[ciclohexano-1,1-pirano[3,4-b]indol]-4-amina cristalina

Info

Publication number
AR087081A1
AR087081A1 ARP120102454A ARP120102454A AR087081A1 AR 087081 A1 AR087081 A1 AR 087081A1 AR P120102454 A ARP120102454 A AR P120102454A AR P120102454 A ARP120102454 A AR P120102454A AR 087081 A1 AR087081 A1 AR 087081A1
Authority
AR
Argentina
Prior art keywords
fluoro
dimethyl
phenyl
cyclhexan
espiro
Prior art date
Application number
ARP120102454A
Other languages
English (en)
Spanish (es)
Inventor
Dr Gru Michael
Dr Kluge Stefan
Dr Prhs Stefan
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of AR087081A1 publication Critical patent/AR087081A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
ARP120102454A 2011-07-08 2012-07-06 (1r,4r)-6-fluoro-n,n-dimetil-4-fenil-4,9-dihidro-3h-espiro[ciclohexano-1,1-pirano[3,4-b]indol]-4-amina cristalina AR087081A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11005587 2011-07-08

Publications (1)

Publication Number Publication Date
AR087081A1 true AR087081A1 (es) 2014-02-12

Family

ID=46717800

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120102454A AR087081A1 (es) 2011-07-08 2012-07-06 (1r,4r)-6-fluoro-n,n-dimetil-4-fenil-4,9-dihidro-3h-espiro[ciclohexano-1,1-pirano[3,4-b]indol]-4-amina cristalina

Country Status (23)

Country Link
US (2) US8618156B2 (https=)
EP (2) EP3235821B1 (https=)
JP (2) JP6276689B2 (https=)
CN (2) CN103649094B (https=)
AR (1) AR087081A1 (https=)
AU (2) AU2012283449B2 (https=)
BR (1) BR112014000358A2 (https=)
CA (1) CA2841032C (https=)
CY (1) CY1120525T1 (https=)
DK (2) DK2729470T3 (https=)
EA (1) EA026750B1 (https=)
ES (1) ES2641299T3 (https=)
HR (1) HRP20170968T1 (https=)
HU (1) HUE033043T2 (https=)
IL (1) IL230331B (https=)
LT (1) LT2729470T (https=)
MX (1) MX2014000297A (https=)
PL (1) PL2729470T3 (https=)
PT (1) PT2729470T (https=)
RS (1) RS56343B1 (https=)
SI (1) SI2729470T1 (https=)
TW (1) TWI585092B (https=)
WO (1) WO2013007361A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103649094B (zh) * 2011-07-08 2017-05-24 格吕伦塔尔有限公司 晶态的(1r,4r)‑6’‑氟‑N,N‑二甲基‑4‑苯基‑4’,9’‑二氢‑3’H‑螺[环己烷‑1,1’‑吡喃并[3,4,b]吲哚]‑4‑胺
JP6673924B2 (ja) 2015-01-23 2020-03-25 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 肝機能障害および/または腎機能障害を有する対象における疼痛を治療するためのセブラノパドール
EP3253374B1 (en) 2015-02-02 2018-11-28 ratiopharm GmbH Composition comprising cebranopadol in a dissolved form
JP7373904B2 (ja) 2016-02-29 2023-11-06 パーク・セラピューティクス・インコーポレイテッド セブラノパドールの滴定
CN112313202A (zh) * 2019-05-21 2021-02-02 江苏众强药业有限公司 曲前列尼尔钠盐新晶型及制备方法
CN112254496A (zh) * 2020-09-25 2021-01-22 榆林学院 一种煤泥收集装置
WO2024129782A1 (en) 2022-12-12 2024-06-20 Park Therapeutics, Inc. Regimens and compositions useful for alleviating pain
EP4665333A1 (en) 2023-02-15 2025-12-24 Adneuris Therapeutics, Inc. Regimens and compositions useful for alleviating pain
WO2026035694A1 (en) 2024-08-05 2026-02-12 Adneuris Therapeutics, Inc. Cebranopadol useful for preventing or reducing opioid induced respiratory depression

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10252667A1 (de) 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102005016460A1 (de) 2005-04-11 2006-10-19 Grünenthal GmbH Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
DE102006033109A1 (de) * 2006-07-18 2008-01-31 Grünenthal GmbH Substituierte Heteroaryl-Derivate
DE102006046745A1 (de) 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
KR20130097173A (ko) * 2010-08-04 2013-09-02 그뤼넨탈 게엠베하 신경병증성 통증을 치료하기 위한 6’­플루오로­(N­메틸­ 또는 N,N­디메틸­)­4­페닐­4’,9’­디하이드로­3’H­스피로[사이클로헥산­1,1’­피라노[3,4,b]인돌]­4­아민을 포함하는 약제학적 투여형
CN103649094B (zh) * 2011-07-08 2017-05-24 格吕伦塔尔有限公司 晶态的(1r,4r)‑6’‑氟‑N,N‑二甲基‑4‑苯基‑4’,9’‑二氢‑3’H‑螺[环己烷‑1,1’‑吡喃并[3,4,b]吲哚]‑4‑胺

Also Published As

Publication number Publication date
US20130012563A1 (en) 2013-01-10
CN103649094A (zh) 2014-03-19
EP2729470A1 (en) 2014-05-14
RS56343B1 (sr) 2017-12-29
MX2014000297A (es) 2014-01-31
DK2729470T3 (en) 2017-09-11
AU2012283449A1 (en) 2014-02-20
AU2012283449B2 (en) 2017-04-06
WO2013007361A8 (en) 2013-04-04
CA2841032C (en) 2020-12-15
EA201400120A1 (ru) 2014-06-30
SI2729470T1 (sl) 2017-10-30
BR112014000358A2 (pt) 2017-01-10
PT2729470T (pt) 2017-10-02
CY1120525T1 (el) 2019-07-10
EP3235821A1 (en) 2017-10-25
AU2017204572B2 (en) 2018-05-24
TW201311694A (zh) 2013-03-16
JP2017081981A (ja) 2017-05-18
LT2729470T (lt) 2017-08-25
DK3235821T3 (da) 2020-04-20
EA026750B1 (ru) 2017-05-31
JP6559165B2 (ja) 2019-08-14
CA2841032A1 (en) 2013-01-17
WO2013007361A9 (en) 2013-12-27
JP6276689B2 (ja) 2018-02-07
IL230331B (en) 2018-11-29
HUE033043T2 (hu) 2017-11-28
HRP20170968T1 (hr) 2017-09-22
US20130231381A1 (en) 2013-09-05
US8765800B2 (en) 2014-07-01
EP2729470B1 (en) 2017-06-21
US8618156B2 (en) 2013-12-31
AU2012283449A8 (en) 2014-03-27
AU2017204572A1 (en) 2017-07-27
TWI585092B (zh) 2017-06-01
ES2641299T3 (es) 2017-11-08
PL2729470T3 (pl) 2017-11-30
CN103649094B (zh) 2017-05-24
JP2014518226A (ja) 2014-07-28
WO2013007361A1 (en) 2013-01-17
CN106939005A (zh) 2017-07-11
EP3235821B1 (en) 2020-04-08

Similar Documents

Publication Publication Date Title
AR087081A1 (es) (1r,4r)-6-fluoro-n,n-dimetil-4-fenil-4,9-dihidro-3h-espiro[ciclohexano-1,1-pirano[3,4-b]indol]-4-amina cristalina
NI201400142A (es) Formas cristalinas de un modulador del receptor de androgenos
UY32809A (es) Compuestos y composiciones como inhibidores de cinasa s y k
GT201400142A (es) Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CL2013000225A1 (es) Forma de dosificacion farmaceutica que contiene 6´-fluoro-(n-metil)-o-n,n,-dimetil)-4-fenil-4´,9´-dihidro-3´-h-espiro[ciclohexan-1,1´-pirano[3,4,b])indol]-4-amina para el tratamiento de dolor neuropatico.
MX351507B (es) Composiciones farmaceuticas de co- cristales de tramadol y coxibs.
ECSP10010129A (es) Inhibidores de quinasas símil polo
PE20180318A1 (es) Procedimiento para preparar isoquinolinonas y formas solidas de isoquinolinonas
ECSP12011720A (es) Compuestos heterocíclicos y usos de los mismos
CR20160222U (es) Formas solidas de acido { [ -(3- clorofenil) -3- hidroxipiridin -2-carbonil] amino} acetico, composiciones, y usos de las mismas
CL2012000508A1 (es) Composicion para la aplicacion en cultivos agricolas al aire libre o invernaderos que comprende zeolita, y aditivos; uso de la composicion para aumentar el rendimiento de los cultivos agricolas.
ECSP14026138A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
GT201600017A (es) Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
ECSP099620A (es) Derivados de ciclohexano espirociclico
CO6660435A2 (es) Una forma cristalina de clorhidrato de (r) -7- cloro-n- (quinuclidin -3-il)benzo[b] tiofeno-2- carboxamida monohodratado
CO2017000443A2 (es) Derivados de 3h, 4h, 6h, 7h-piran[3,4-d]imidazol-4-ona activos como inhibidores de la aldosterona sintasa
BR112016001876A2 (pt) composto de benzoxaborol tricíclico, método de preparação e uso do mesmo
GT201300304A (es) 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia
BR112014014202A2 (pt) formas sólidas de cloridrato de (1r,4r)-6'-fluoro-n,n-dimetil-4-fenil-4',9'-dihidro-3'h-espiro-[ciclohexano-1,1'-pirano[3,4,b]indol]-4-amina
GT201500124A (es) Forma sòlida de un derivado de dihidro-pirido-oxazina
ES2403549R1 (es) Co-cristales de agomelatina con formadores de co-cristales
AR090830A1 (es) Cocristales de metalaxil y protioconazol y procedimientos para la fabricacion y el uso de los mismos
BR112015022509A2 (pt) forma cristalina de cis-(e)-4-(3-fluorofenil)-2',3',4',9'-tetra-hidro-n,n-dimetil-2'-(1-oxo-3-fenil-2-propenil)-espiro[ciclohexano-1,1'[1h]-pirido[3,4-b]indol]-4-amina cristalina
MX2013007504A (es) Composiciones y metodos de uso de formas cristalinas de analogos de wortmanina.
CR20150068A (es) Ciclopentilpirazoles como bloqueadores del canal de calcio tipo n

Legal Events

Date Code Title Description
FC Refusal